The Chicago Entrepreneur

The Wall Street Journal: Japan approves COVID antiviral pill as Pfizer, Merck alternative

Japan approved an antiviral pill from Shionogi & Co. to treat Covid-19 after the company provided new data to show the drug’s efficacy.

Previous post Coronavirus tally: China counts more than 253,000 COVID cases in three weeks as daily average rises
Next post Stocks making the biggest moves premarket: Best Buy, Dick’s Sporting, Abercrombie & Fitch and others